Peptide Research Glossary

A reference guide to key terms used in peptide research and laboratory supply. Intended for researchers and laboratory professionals working across the UAE.

Amino Acid: The fundamental building blocks of peptides and proteins. Each amino acid contains an amino group, a carboxyl group, and a side chain that determines its chemical properties. Peptides are formed by linking amino acids together via peptide bonds.
Angiogenesis: The process by which new blood vessels form from existing vasculature. Angiogenesis is a critical component of tissue repair, as new vessel formation delivers oxygen and nutrients to damaged tissue. Several research peptides including BPC-157 are studied for their pro-angiogenic activity.
Bacteriostatic Water: Sterile water containing 0.9% benzyl alcohol, used as a solvent for reconstituting lyophilised peptides. The benzyl alcohol inhibits bacterial growth, extending the usable life of a reconstituted solution compared to standard sterile water.
BPC-157: Body Protection Compound-157. A synthetic pentadecapeptide derived from a protective protein found in human gastric juice. One of the most extensively studied tissue repair peptides in published preclinical literature, with research spanning musculoskeletal, gastrointestinal, neurological, and vascular biology. Read research overview.
Certificate of Analysis (CoA): A document produced by an independent laboratory confirming the identity, purity, and potency of a compound. A batch-specific CoA verified by HPLC and mass spectrometry is the minimum documentation standard for research-grade peptide supply.
GHK-Cu: Glycyl-L-histidyl-L-lysine copper complex. A naturally occurring copper peptide studied extensively in wound healing, collagen synthesis, skin biology, and anti-inflammatory research contexts.
GLP-1 (Glucagon-Like Peptide-1): An incretin hormone produced in the gut in response to food intake. GLP-1 receptor agonists are a class of compounds extensively studied for their role in glucose regulation and metabolic research. Semaglutide and retatrutide both engage the GLP-1 receptor.
HPLC (High-Performance Liquid Chromatography): An analytical technique used to separate, identify, and quantify components in a mixture. HPLC is the primary method used to verify peptide purity in Certificate of Analysis documentation.
Ipamorelin: A selective growth hormone secretagogue and ghrelin receptor agonist. Studied for its role in stimulating growth hormone release with high selectivity, without significantly affecting cortisol or prolactin levels in animal models.
Lyophilisation: Also known as freeze-drying. A preservation process in which a compound is frozen and then dried under vacuum to remove water content. Lyophilised peptides are more stable during storage and transit than liquid formulations, making this the standard format for research-grade peptide supply.
Mass Spectrometry: An analytical technique that measures the mass-to-charge ratio of ions to identify and characterise compounds at the molecular level. Used alongside HPLC in CoA documentation to confirm the molecular identity of a peptide.
MOTS-c: Mitochondrial Open Reading Frame of the 12S rRNA-c. A mitochondrial-derived peptide studied for its role in metabolic regulation, insulin sensitivity, and energy homeostasis. Research has examined its activity in skeletal muscle and its relationship to AMPK signalling pathways.
NAD+ (Nicotinamide Adenine Dinucleotide): A coenzyme found in all living cells, central to cellular energy metabolism and redox reactions. NAD+ levels decline with age in animal models. It is studied in the context of longevity research, mitochondrial function, and sirtuin pathway activation.
Nitric Oxide (NO) Pathway: A signalling pathway involving nitric oxide, a gaseous molecule that plays a central role in regulating blood vessel tone, inflammation, and tissue repair. BPC-157 is studied for its modulation of nitric oxide signalling, which contributes to its vascular and tissue repair activity profile.
Peptide: A short chain of amino acids linked by peptide bonds. Peptides are distinguished from proteins primarily by length - typically fewer than 50 amino acids. Research peptides are synthetic compounds designed to replicate or study the activity of naturally occurring peptides in biological systems.
Peptide Bond: The covalent chemical bond formed between the carboxyl group of one amino acid and the amino group of another, releasing a water molecule in the process. Peptide bonds form the backbone of all peptide and protein structures.
Retatrutide (LY3437943): An investigational once-weekly triple hormone receptor agonist developed by Eli Lilly. Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors in a single molecule. It is the most advanced triple agonist compound in published clinical literature, currently in Phase 3 trials. Read research overview.
Semaglutide: A GLP-1 receptor agonist studied extensively in metabolic and glycaemic research. Semaglutide is approved as a therapeutic agent in multiple jurisdictions under various brand names. BodyPharm UAE supplies semaglutide strictly for laboratory research use only. Read research overview.
TB-500: The synthetic form of Thymosin Beta-4, a naturally occurring 43 amino acid peptide. TB-500 regulates actin dynamics and cell migration, and is studied for its role in tissue repair, wound healing, and anti-inflammatory activity. Frequently studied alongside BPC-157 due to their mechanistically complementary pathways. Read research overview.
Tesamorelin: A synthetic analogue of growth hormone-releasing hormone (GHRH) containing 44 amino acids. Studied for its role in growth hormone axis research and metabolic biology.
Thymosin Beta-4 (Tb4): A naturally occurring 43 amino acid peptide found in virtually every cell in the body. TB-500 is the synthetic research form of Thymosin Beta-4. Its primary molecular function is sequestering G-actin, thereby regulating cytoskeletal dynamics and cell migration.
Triple Agonist: A compound that simultaneously activates three distinct receptor pathways. In the context of metabolic peptide research, triple agonism refers specifically to combined GLP-1, GIP, and glucagon receptor activation, as studied in retatrutide.
VEGFR2 (Vascular Endothelial Growth Factor Receptor 2): A receptor tyrosine kinase that plays a central role in angiogenesis and vascular development. BPC-157 has been studied for its association with VEGFR2 activation, contributing to its pro-angiogenic research profile.

BodyPharm products are sold strictly for research purposes only and are not intended for human consumption, diagnosis, or treatment.